LY3437943
Price range: AUD185 through AUD668
Buy LY3437943 online | LY3437943 for sale
Retatrutide (LY3437943) is a synthetic research peptide consisting of 39 amino acids. It is studied in control laboratory models for its role in activating three different receptors. These receptors include:
- Glucagon–like peptide‑1 receptor (GLP–1R).
- Glucose–dependent insulinotropic polypeptide receptor (GIPR).
- Glucagon receptor (GCGR).
In controlled laboratory environments, researchers study retatrutide to evaluate its receptor-binding characteristics and downstream cellular signaling activity.
The peptide has also garnered attention for endocrine and receptor-signaling research.
Researchers believe that Retatrutide’s ability to target multiple receptors at the same time distinguishes it from single-targeted research peptides.
Chemical and Molecular Properties
| PubChem CID | 171390338 |
| Molecular Formula | C221H342N46O68 |
| Molecular Weight | 4731 g/mol |
| Synonyms | Retatrutide 2381089-83-2 LY3437943 orb1981169 EX-A7826E…. |
| IUPAC | 20-[[(1S)-4-[2-[2-[2-[[(5S)-5-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(….. |
| CAS | 2381089-83-2 |
| Labeling | Research Use Only (RUO), not for human or animal consumption. |
| Chemical Structure Depiction | ![]() |
| Purity | ≥99% (HPLC verified) |
| Classification | Research Use Only (RUO) |
| Storage Temperature | Lyophilized: −20 °C or colder |
| Solubility | Water, DMSO (research-grade solvents) |
| Safety | Handle with gloves, a lab coat, eye protection; use a fume hood if dust/aerosol is possible |
Working Mechanism of Retatrutide
In controlled laboratory investigations, Retatrutide appears to bind to and activate three primary receptors.
GLP–1 Receptors (GLP–1R):
Investigated for its interaction with GLP-1 receptor–mediated cellular signaling pathways in preclinical research settings.
GIP Receptors (GIPR):
Explored for GIP receptor–associated signaling activity in controlled in vitro experimental models.
Glucagon Receptors (GCGR):
Studied for receptor-mediated intracellular signaling pathways associated with glucagon receptor activation under controlled laboratory conditions.
Retatrutide Research Applications (Laboratory Use Only)
Researchers investigate retatrutide in laboratory models to characterize receptor activation profiles and intracellular signaling responses.
- Retatrutide is being explored for coordinated activation of GLP‑1R, GIPR, and GCGR.
- It is being investigated for receptor-mediated signaling networks and downstream intracellular pathways in vitro.
- Retatrutide is studied for receptor-binding characteristics and downstream intracellular signaling responses in laboratory assays.
Why Choose Purerawz for Retatrutide?
Buy Retatrutide for laboratory research use from our online shop. At Purerawz, we provide high-quality reference materials. Each research compound comes with a Certificate of Analysis for verification of purity and concentration.
Note:
Retatrutide (LY3437943) is an investigational compound currently undergoing clinical evaluation and has not been established as safe or effective for any therapeutic use
Disclaimer
This information is for educational purposes only and not medical advice. Products are for research use only. Research must follow IRB or IACUC guidelines. Verify information independently before purchasing. By ordering, you agree to our Terms and Conditions.
ATTENTION: All our products are for LABORATORY AND RESEARCH PURPOSES ONLY, not for veterinary or human use
Frequently Asked Questions
What is LY3437943 (Retatrutide-class)?
LY3437943 is a retatrutide-class peptide studied as a triple agonist at the GLP-1, GIP and glucagon receptors in metabolic research. PureRawz Australia supplies it as a reference material for laboratory research use only, not for human or veterinary use.
Is LY3437943 (Retatrutide-class) legal or approved in Australia?
LY3437943 is not an approved therapeutic good in Australia and is offered strictly for laboratory research. The researcher is responsible for ensuring compliance with TGA regulations and all applicable Australian laws.
How is LY3437943 (Retatrutide-class) tested?
Each batch is characterised by independent third-party laboratories using HPLC and mass spectrometry, targeting a purity of at least 99%. A batch-specific Certificate of Analysis (COA) accompanies the material.
Tirzepatide vs retatrutide: how do they differ as research peptides?
Tirzepatide is described in the literature as a dual GLP-1/GIP agonist, whereas retatrutide-class peptides such as LY3437943 add glucagon receptor activity as triple agonists. Both are supplied here only as reference materials for laboratory investigation.
For laboratory and research use only. This product is not for human or veterinary consumption, and nothing on this page is medical advice. Researchers are responsible for compliance with all applicable Australian laws (including TGA regulations) and institutional guidelines.
| Form | Peptide, Nasal Spray, Sublingual Tablets |
|---|---|
| Strength | 5mg, 8mg, 10mg, 12mg, 100mcg per spray/10ml/10mg, 300mcg per tablet/30ct/9mg, 300mcg per tablet/60ct/18mg |































Reviews
There are no reviews yet.